Tags: Drug.

Mofegiline (MDL-72974) is a selective irreversible inhibitor of monoamine oxidase B (MAO-B) and semicarbazide-sensitive amine oxidase (SSAO) which was under investigation for the treatment of Parkinson’s disease and Alzheimer’s disease but was never marketed.

Mofegiline.svg
ATC prefix
None
CAS number
119386-96-8
FDA UNII code
1FMJ6D8Y1B
IUPAC name
(2E)-2-(fluoromethylidene)-4-(4-fluorophenyl)butan-1-amine
PubChem
6437850

Loading...

This page contains content from the copyrighted Wikipedia article "Mofegiline"; that content is used under the GNU Free Documentation License (GFDL). You may redistribute it, verbatim or modified, providing that you comply with the terms of the GFDL.